Lecture 4: Assessing Diagnostic and Screening Tests

Slides:



Advertisements
Similar presentations
Validity and Reliability of Analytical Tests. Analytical Tests include both: Screening Tests Diagnostic Tests.
Advertisements

Lecture 3 Validity of screening and diagnostic tests
The Research Consumer Evaluates Measurement Reliability and Validity
Azita Kheiltash Social Medicine Specialist Tehran University of Medical Sciences Diagnostic Tests Evaluation.
GerstmanChapter 41 Epidemiology Kept Simple Chapter 4 Screening for Disease.
Epidemiology Kept Simple Chapter 4 Screening for Disease.
1 Comunicación y Gerencia 18/4/2011Dr Salwa Tayel (Screening) بسم الله الرحمن الرحيم.
Screening. Screening refers to the application of a test to people who are as yet asymptomatic for the purpose of classifying them with respect to their.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
Screening for Disease Guan Peng Department of Epidemiology School of Public Health, CMU.
Screening and Early Detection Epidemiological Basis for Disease Control – Fall 2001 Joel L. Weissfeld, M.D. M.P.H.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
David Yens, Ph.D. NYCOM PASW-SPSS STATISTICS David P. Yens, Ph.D. New York College of Osteopathic Medicine, NYIT l PRESENTATION.
Statistics in Screening/Diagnosis
BASIC STATISTICS: AN OXYMORON? (With a little EPI thrown in…) URVASHI VAID MD, MS AUG 2012.
Multiple Choice Questions for discussion
1 Evaluating Model Performance Lantz Ch 10 Wk 5, Part 2 Right – Graphing is often used to evaluate results from different variations of an algorithm. Depending.
Basic statistics 11/09/13.
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
Principles and Predictive Value of Screening. Objectives Discuss principles of screening Describe elements of screening tests Calculate sensitivity, specificity.
Basic Ideas and Terminology Ettore Beghi Institute for Pharmacological Research Mario Negri, Milano, Italy.
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
Dr K N Prasad Community Medicine
Step 3 of the Data Analysis Plan Confirm what the data reveal: Inferential statistics All this information is in Chapters 11 & 12 of text.
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
Evaluation of Diagnostic Tests
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
Probability. Statistical inference is based on a Mathematics branch called probability theory. If a procedure can result in n equally likely outcomes,
Advanced Physical therapy Procedures Ahmed alhowimel.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
1 Epidemiological Measures I Screening for Disease.
Chapter 10 Screening for Disease
Screening Puja Myles
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
SCREENING TTTThe search for unrecognized disease or defect by means of rapidly applied tests, examinations or other procedures in apparently healthy.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
HSS4303B – Intro to Epidemiology Feb 8, Agreement.
Diagnostic Tests Afshin Ostovar Bushehr University of Medical Sciences Bushehr, /7/20151.
Positive Predictive Value and Negative Predictive Value
1 Wrap up SCREENING TESTS. 2 Screening test The basic tool of a screening program easy to use, rapid and inexpensive. 1.2.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
Evidence based medicine Diagnostic tests Ross Lawrenson.
10 May Understanding diagnostic tests Evan Sergeant AusVet Animal Health Services.
Inter-observer variation can be measured in any situation in which two or more independent observers are evaluating the same thing Kappa is intended to.
BIOSTATISTICS Lecture 2. The role of Biostatisticians Biostatisticians play essential roles in designing studies, analyzing data and creating methods.
RELIABILITY OF DISEASE CLASSIFICATION Nigel Paneth.
Handbook for Health Care Research, Second Edition Chapter 11 © 2010 Jones and Bartlett Publishers, LLC CHAPTER 11 Statistical Methods for Nominal Measures.
SCREENING FOR DISEASE. Learning Objectives Definition of screening; Principles of Screening.
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
Biostatistics Board Review Parul Chaudhri, DO Family Medicine Faculty Development Fellow, UPMC St Margaret March 5, 2016.
© 2010 Jones and Bartlett Publishers, LLC. Chapter 12 Clinical Epidemiology.
Sensitivity:DISEASE Specificity:PRESENTABSENT TEST RESULTS POSITIVEAbA+b NEGATIVECdC+d a+cb+da+b+c+d Lets recall the 2x2 contingency table Probability.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
CHP400: Community Health Program-lI Mohamed M. B. Alnoor Muna M H Diab SCREENING.
Screening for Disease: Part One
Oral Health Training & Calibration Programme
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Diagnostic Test Studies
Principles of Epidemiology E
Class session 7 Screening, validity, reliability
EPIDEMIOLOGICAL METHOD TO DETERMINE UTILITY OF A DIAGNOSTIC TEST
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
Comunicación y Gerencia
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
How do we delay disease progress once it has started?
Diagnosis II Dr. Brent E. Faught, Ph.D. Assistant Professor
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
Evidence Based Diagnosis
Presentation transcript:

Lecture 4: Assessing Diagnostic and Screening Tests Reading: Gordis - Chapter 4 Lilienfeld and Stolley - Chapter 6, pp. 117-125

Screening “Screening is the application of a test to people who are asymptomatic for the purpose of classifying a person with respect to their likelihood of having a particular disease” Screening, in and of itself, does not diagnose disease. Persons who test positive are referred to physicians for more detailed assessment Physicians determine the presence or absence of disease. Screening is one of the most practical applications of epidemiology. It’s goal is to promote health and prevent disease.

Screening Decision Tree Negative result Perform screening test Record the result Inform the person screened Positive result Negative result Perform diagnostic test Record the result Inform the patient Positive result Revise treatment and reevaluate Start treatment Negative response Screening Decision Tree Positive response Continue treatment and reevaluate

Outcomes in a screening test False positive – when a screening test indicates that the individual has a disease but the person in fact does not have the disease. False negative – when a screening test indicates that the individual does not have a disease but the person in fact has the disease. True positive – when the test says the person has a disease and the person indeed has the disease. True negative – when the test says the person does not have the disease and the person in fact is disease free.

Screening tests Validity of test is shown by how well the test actually measures what it is supposed to measure. Validity is determined by the sensitivity and specificity of the test. Reliability is based on how well the test does in use over time - in its repeatability.

Sensitivity and specificity: tests of validity Sensitivity is the ability of a screening procedure to correctly identify those who have the disease--the percentage of those who have the disease and are proven to have the disease as demonstrated by a diagnostic test. Specificity is the ability of a screening procedure to correctly identify the percentage of those who do not have the disease--those who do not have the disease and are proven to not have the disease as demonstrated by a diagnostic test.

Diagnosed disease status Screening Diagnosed disease status Positive Negative Total Screening test a=true positive b=false positive a+b c=false negative d=true negative c+d a+c b+d Sensitivity = a b+c Specificity = d b+d

Sensitivity and specificity of breast cancer screening examination Cancer confirmed Cancer not confirmed Total Screening test Positive 132 983 1155 Negative 45 63,650 63,695 177 64,633 64,820 Sensitivity = 132/177 = 74.6% Specificity = 63650/64633 = 98.5%

Screening Positive predictive value – Probability that a person actually has the disease given a positive screening test Negative predictive value – Probability that a person is actually disease-free given a negative screening test

Screening Positive predictive value = Negative predictive value = a d Diagnosed disease status Positive Negative Total Screening test a b a+b c d c+d a+c b+d Positive predictive value = a a+b Negative predictive value = d c+d

Prevalence on positive predictive value with constant sensitivity and specificity PV+ Sensitivity Specificity (%) 0.1 1.8 90 95 1.0 15.4 5.0 48.6 50.0 94.7 The higher the prevalence, the higher the predictive value. Screening is most productive if it is applied to a high-risk population.

Cutoff level and validity When the test is a continuous variable, we need a cutoff level to decide positive or negative test result. If increase the sensitivity by lowering the the cutoff level, we decrease the specificity.

Choice of cutoff The choice of cutoff level depends on the importance attached to false positives and false negatives. False positives associated with costs – emotional and financial; false negative associated with missing early detection.

How do we examine the reliability (repeatability)? We do the tests repeatedly in the same individuals and calculate measures of : Intrasubject variation (variation within individual subjects) Interobserver variation (variation between those reading the test results) Overall percent agreement Kappa statistic

Overall percent agreement Reading No. 2 Abnormal Suspect Doubtful Normal a b c d e f g h i J k l m n o p Percent agreement = a+f+k+p Total reading

Kappa statistics We would expect agreement purely by chance. We want to know: To what extent do readers agree beyond what we would expect by chance alone? Answer: calculate Kappa statistics Kappa = Observed agreement (%) - agreement expected by chance alone (%) 100% - agreement expected by chance alone (%)

Calculate Kappa statistics Observed table Expected table Observer 1 + - Observer 2 16 2 18 11 27 32 13 45 Observer 1 + - Observer 2 12.8 5.2 18 19.2 7.8 27 32 13 45 Observed agreement = (16+11)/45 = 60% 12.8 = 45x(18/45)x(32/45) 7.8 = 45x(27/45)x(13/45) Expected agreement = (12.8+7.8)/45 = 45.8% Kappa = (60% - 45.8%) / (100%-45.8%) = 0.26

Interpreting the values of Kappa Value of Kappa Strength of agreement 0.0 No agreement <0.2 Poor 0.21-0.4 Fair 0.41-0.6 Moderate 0.61-0.8 Good 0.81-1.00 Very good

Validity vs reliability Test results Reliable but invalid Valid but not reliable Both valid and reliable True value